Close this search box.

We are creating some awesome events for you. Kindly bear with us.

NUS scientists develop novel microfluidic chip for fast, accurate and low-cost disease detection

NUS scientists develop novel microfluidic chip for fast

A team of researchers from the National University of
Singapore (NUS) developed
an innovative microfluidic chip that promise for a faster and cheaper way to
diagnose diseases with high accuracy.

Professor Zhang Yong from the Department of Biomedical
Engineering at the NUS Faculty of Engineering and his team have developed a
tiny microfluidic chip that could effectively detect minute amounts of
biomolecules without the need for complex lab equipment.

The low-cost microfluidic chip can quickly and
accurately detect and quantify nano-bioparticles using only a standard
laboratory microscope without any fluorescent labels.

“Our invention is an example of disruptive diagnostics. This
tiny biochip can sensitively detect proteins and nano-sized polymer vesicles
with a concentration as low as 10ng/mL (150 pM) and 3.75μg/mL respectively. It
also has a very small footprint, weighing only 500 mg and is 6mm³ in size.
Detection can be performed using standard laboratory microscopes, making this
approach highly attractive for use in point-of-care diagnostics,” explained
Prof Zhang. 

Disease diagnosis requires identification and quantification
of various bioparticles such as DNA, RNA, proteins, virus, exosomes, and
bacteria. Typically, detection of biomolecules using colorimetric assays or
fluorescent labelling increase detection cost and complexity as they rely on
expensive optical systems and involvement of multiple sample processing steps
requiring minimum sample volumes.

One alternative to reduce cost in disease diagnosis is the
adoption of fluorescent label-free bioparticle detection techniques. This
approach requires precision engineering of nano-features in a detection chip,
complex optical setups, novel nano-probes such as graphene oxide, carbon
nanotubes, and gold nanorods, or additional amplification steps such as
aggregation of nanoparticles to achieve sensitive detection of biomarkers.

The innovation by the NUS team adopts the novel fluorescent
label-free approach that uses the lateral shifts in the position of the
microbead substrate in pillar arrays, for quantifying the biomolecules, based
on the change in surface forces and size, without the need of any external

Due to the usage of lateral displacement, the
nano-biomolecules can be detected in real-time and the detection is
significantly faster in comparison to fluorescent label based detection.  

“These techniques can also be extended to many other types
of nano-biomolecules, including nucleic acid and virus detection,” said Prof

To complement this chip technology, Prof Zhang said his team
is also developing a portable smartphone-based accessory and microfluidic pump
to make the whole detection platform portable for outside laboratory disease
diagnostics, in the hope of further developing this technology for

His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD
students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in
scientific journal Nature
on 28 March 2018.

This study was supported by a research grant
from the Singapore Ministry of Education.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and consulting services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,800 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently, and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity, and service. For more information, visit